Prostacure

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prostacure

Property Description
Active Ingredient Tamsulosin Hydrochloride
Form Capsule (Modified-Release)
Pharmacological Class Alpha-Blocker
Common Use Symptomatic relief for prostatic issues
Origin Synthetic Compound

Prostacure is a prescription-only, synthetic medicine classified as an Alpha-Blocker, specifically an Alpha-1 Adrenergic Receptor Antagonist. Its composition is a single-component formula containing the active ingredient Tamsulosin Hydrochloride, which is designed to be administered via the oral route, typically in the form of a modified-release capsule. Tamsulosin Hydrochloride is a chemically synthesized compound. This specific formulation is distinguished by its modified-release properties, a delivery feature to ensure the sustained and steady action of the active compound over an extended duration.


The Drug's Purpose and Action

The general purpose of Prostacure is to facilitate the flow of urine by achieving smooth muscle relaxation in the lower urinary tract. This selective relaxation is the core functional benefit for providing symptomatic relief in men with prostatic disorders. The medication functions by selectively inhibiting alpha-1 adrenergic receptors located in the prostate gland and the neck of the bladder. This targeted action decreases muscular tension in the tissues, which in turn leads to a significant reduced resistance at the bladder outlet. This mechanism is used to improve the ability to urinate in men facing difficulties due to prostate enlargement. The primary goal is addressing the mechanical block and improving overall urinary dynamics.

Regulatory References

  1. MedlinePlus Tamsulosin Use

What side effects are possible with Prostacure?

Safety Information and Possible Side Effects

The most common adverse reactions reported with Prostacure in clinical trials were related to sexual function. These generally occurred more frequently than with placebo and included impotence (trouble getting or keeping an erection), decreased libido, and decreased volume of ejaculate.

Less Common and Postmarketing Reactions

Side effects reported less frequently or through postmarketing surveillance include:

  • Breast Disorders: Enlargement or tenderness of the breasts; rarely reported male breast cancer.
  • Hypersensitivity: Allergic reactions, including rash, hives, and swelling of the lips, tongue, throat, and face.
  • Psychiatric: Depression and, specifically, suicidal thoughts and behavior have been reported in patients taking the medication.
  • Other: Testicular pain, problems with ejaculation or erection that continued after stopping the medication, and male infertility/poor semen quality.

Critical Safety Considerations

  1. Risk to Fetus: Prostacure is contraindicated in women who are or may potentially be pregnant. Women who are pregnant or may become pregnant must not handle crushed or broken tablets due to the risk of causing abnormalities of the external genitalia in a male fetus if the active ingredient is absorbed.
  2. Prostate Cancer Risk: Regulatory documents indicate that the drug may increase the risk of being diagnosed with a more serious, high-grade form of prostate cancer (Gleason score 8–10).
  3. PSA Monitoring: Prostacure decreases serum Prostate Specific Antigen (PSA) levels by approximately 50%. This effect must be considered when interpreting PSA test results. Any confirmed increase in PSA from its lowest level while on the drug should be evaluated for the potential presence of prostate cancer.

Overdose and Emergency Response

Prostacure Overdose and When to Seek Help

An overdose of Prostacure (Tamsulosin Hydrochloride) is officially documented as an event that can lead to severe, acute systemic hypotension, a pronounced and clinically significant decrease in blood pressure. The primary manifestation of excessive exposure to this alpha-blocker is the risk of cardiovascular compromise, which may present as profound dizziness or syncope (fainting).

Regulatory prescribing information mandates that patients or caregivers seek immediate medical attention or contact emergency services upon the suspicion or manifestation of overdose symptoms. This urgent requirement is due to the potential for life-threatening cardiovascular instability.

Management of an overdose relies entirely on symptomatic and supportive treatment because no specific antidote is known. The official procedural goal is the restoration of blood pressure and circulating volume. This typically involves measures such as positioning the patient in a supine position, administering fluid replacement, and, if necessary, using vasopressor agents to support circulation. Further official instructions include the consideration of gastric decontamination (e.g., activated charcoal or gastric lavage) if ingestion occurred recently. Hospital monitoring of vital signs is mandated until the patient's condition has stabilized.

Therapeutic Uses of Prostacure

What Prostacure Treats: Main Uses and Benefits

Prostacure (Tamsulosin) is generally used to help manage the lower urinary tract symptoms associated with Benign Prostatic Hyperplasia (BPH), which is relevant in conditions characterized by periods of heightened symptoms. The medication is applied to provide symptomatic support where needed. It is commonly used to help manage symptoms such as difficulty starting urination, a weak or intermittent urine stream, the feeling of incomplete bladder emptying, increased urinary frequency, and urgency.

Symptomatic Relief for Voiding and Storage

This medication addresses symptoms that interfere with daily functioning and create noticeable physiological strain. It helps ease burdensome obstructive symptoms, such as the need for effortful straining, and may assist in easing the effort associated with urination. Prostacure supports the patient during difficult episodes by easing distress. It is also used for managing irritative symptoms, often during phases when they become more noticeable.

This medication is primarily relevant for easing symptoms that disrupt sleep and interfere with routine daily activities.

This provides support that contributes to easing the overall symptom load and supports patients during difficult episodes by easing distress, such as those related to nocturia (waking up at night to urinate).

Quick Fact: Supports Management of Obstructive and Irritative LUTS (Lower Urinary Tract Symptoms).

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for Prostacure (Tamsulosin Hydrochloride) is strictly defined by regulatory authorities based on age, sex, organ function, and specific medical history. Only adult males are the approved population, as the medicine is not indicated for use in women or the pediatric population (under 18 years of age). Safety and effectiveness have not been established in these excluded groups.


Contraindications and Restrictions

Use of Prostacure is contraindicated (must not be used) in patients with a known hypersensitivity to tamsulosin or any of its components, and in those with a history of orthostatic hypotension.

Eligibility is further restricted by organ health and concurrent conditions:

Condition Eligibility Classification
Severe Hepatic Insufficiency Contraindicated (Must not be used).
Severe Renal Impairment (CrCl < 10 mL/min) Use with caution (Patients have not been studied).
Scheduled Cataract/Glaucoma Surgery Initiation is not recommended before surgery.
Prostate Cancer Mandatory screening is required before and during treatment.
CYP2D6 Poor Metabolizers Use with caution, particularly at doses above 0.4 mg.

For older adults (Geriatric Patients), no overall differences in efficacy or safety were observed compared to younger patients, and no specific restrictions limit its usefulness.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Prostacure (Tamsulosin) interaction patterns are defined by its documented metabolism and pharmacodynamic effects. Co-administration is formally contraindicated with Strong CYP3A4 Inhibitors, such as ketoconazole, because these agents significantly increase Tamsulosin plasma exposure (AUC). Similarly, combining Prostacure with Other Alpha Adrenergic Blocking Agents is contraindicated due to the officially described risk of symptomatic hypotension from additive pharmacodynamic effects.

Regulatory documents advise caution when Prostacure is co-administered with Moderate CYP3A4 or CYP2D6 Inhibitors, including medicines like erythromycin and paroxetine, as inhibition of these pathways increases Tamsulosin concentration. A specific restriction dictates that co-administration with a Strong CYP3A4 Inhibitor is formally contraindicated in individuals known to be CYP2D6 Poor Metabolizers.

Caution is also advised for use with PDE5 Inhibitors (e.g., Sildenafil, Tadalafil) due to the potential for additive blood pressure-lowering effects. Furthermore, the official labeling notes that Cimetidine is documented to raise Tamsulosin plasma levels, while Furosemide causes a documented fall in plasma levels. Caution is also advised regarding co-administration with Warfarin, pending conclusive study results.

Mechanism of Action

Selective Alpha-1a Receptor Blockade

Prostacure (Tamsulosin Hydrochloride) exerts its action primarily through the selective antagonism of the Alpha-1a (alpha1A) adrenergic receptors found predominantly on the smooth muscle of the lower urinary tract. This molecular interaction functionally blocks the effects of norepinephrine, preventing the continuous signaling that normally leads to muscle contraction and tension.


Modulation of Sympathetic-Mediated Smooth Muscle Tone

Receptor blockade initiates the modulation of sympathetic-mediated muscle tone, primarily within the prostate and bladder neck. This mechanism initiates a physiological cascade that causes smooth muscle relaxation in the surrounding tissues. By reducing this muscular constriction (the dynamic component of resistance), the molecule lowers resistance at the bladder outlet, which adjusts the flow dynamics of fluid through the lower urinary tract.


Mechanism Constraints

The mechanism is strictly limited to influencing muscle tone and does not alter or reduce the physical mass or volume of the prostate tissue (the static component). The extent of the physiological consequence is dependent upon the proportion of the functional resistance that is driven by muscular tension.

Dosage and Administration Information

How to Use Prostacure — Official Administration Guidelines

Prostacure (Tamsulosin Hydrochloride) is a medicine for oral administration that is used according to established guidelines to ensure the consistent release of the active compound. The modified-release formulation dictates specific rules for dosing, timing, and handling.


Administration Scope

Instruction Detail
Route of administration Oral route using the modified-release capsule form.
Dosing schedule Initial and maintenance dose is 0.4 mg once daily. The dose may escalate to a maximum of 0.8 mg once daily after 2 to 4 weeks if the response to the initial dose is insufficient.
Timing in relation to meals Must be administered approximately one-half hour following the same meal each day.
Age-group administration rules Pediatric Use: Not indicated for use in pediatric populations. No adjustment is typically recommended for mild-to-moderate renal or hepatic impairment.
Missed-dose rules If administration is discontinued or interrupted for several days, therapy is restarted at the 0.4 mg once-daily dose.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral
Frequency pattern Daily (once daily)
Use-context constraints Administration is meal-dependent and subject to dose integrity (swallow whole).

Resulting Procedural Structure

Official step sequence:

  • Take the 0.4 mg modified-release capsule once daily.
  • Administer the capsule approximately 30 minutes after the same meal each day.
  • Swallow the capsule whole; it must not be crushed, chewed, or opened.

Connection to the overall use protocol:

Standardized protocols center on a fixed once-daily, meal-dependent oral administration to maintain consistent levels of the active ingredient. This procedure dictates the required dose-titration timing and prohibits altering the capsule's physical integrity, ensuring the medication is used precisely as intended by its modified-release design.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 3 Trial Data

Research has explored whether Drug X is associated with changes in symptoms of moderate acute pain. A primary Phase 3 trial (N=450) evaluated whether an orally administered dose is associated with pain relief versus placebo.

  • Dose: Studies utilized a dose of 50 mg taken twice daily.
  • Outcome: The primary endpoint was the change in pain scores over a 24-hour period.
  • Findings: The study examined the time to onset of a measurable change in pain perception.

Mechanism of Action Research

Studies have focused on the drug's properties, including selective antagonism of the A2 receptor in the peripheral nervous system. This research examined whether this interaction is related to the anti-nociceptive and anti-inflammatory properties of the compound.

  • Key Finding: Pre-clinical data suggested an interaction at the targeted receptor site that was being investigated for anti-inflammatory effects.
  • Clinical Relevance: Further research is needed to determine the clinical significance of these findings.

Chronic Pain and Combination Studies

Research was evaluated for use in chronic pain management (e.g., osteoarthritis). While Phase 2 trials investigated the potential for improved patient outcomes, a subsequent meta-analysis indicated that evidence was not yet conclusive.

Combination Use with Standard Therapy

Additional research examined the effects of combination use with standard therapy (e.g., NSAIDs). These trials assessed the magnitude of changes in pain levels over time when Drug X was administered alongside other treatments. The current body of evidence does not support a definitive conclusion on superior efficacy.


Safety and Tolerability Profile

The safety analysis included 1,200 participants across all trials. Based on trial data, major safety issues were not reported for short-term use (up to 7 days) at the 50 mg dose.

  • Common Adverse Events: The most frequently reported events included mild nausea and dry mouth.
  • Special Populations: The safety profile in individuals with severe liver conditions was not established during the Phase 3 trials.

Key Studies & References

  1. Novel Nonopioid Analgesic for Acute Pain: FDA Approval and Clinical Utility of Suzetrigine (Mechanism, Efficacy, and Safety Summary)
  2. Phase 3 Trial - Open-Label Study of Suzetrigine in Surgical and Non-surgical Acute Pain Conditions (Safety and Tolerability)

Frequently Asked Questions (FAQ)

Common questions about Prostacure (FAQ)


Q: How quickly should I expect to notice a difference after starting Prostacure?

A: Studies and official information indicate that the active ingredient in Prostacure often begins to work rapidly, with effects sometimes noticeable within a few days of starting treatment. Regulatory pharmacokinetic data suggests the active ingredient generally reaches a steady concentration level in the body after about five days of regular daily dosing.


Q: Can Prostacure be taken long-term, or is it typically a short course of treatment?

A: Regulatory documents refer to safety and efficacy data established for up to 12 months of continuous use in clinical trials. The medication has been studied for continuous symptom management, based on a healthcare provider's direction.


Q: Is there a specific time of day that is best to take Prostacure?

A: Official guidance states that Prostacure should be taken approximately one-half hour following the same meal each day. This specific timing is regulated to ensure consistent absorption and maintain steady levels of the medication in the bloodstream.


Q: What did the main clinical trials on Prostacure show regarding its effectiveness?

A: Clinical trials for the active ingredient (tamsulosin) showed significant improvements in BPH symptoms compared to a placebo. Effectiveness was primarily measured using standardized patient surveys, such as the American Urological Association (AUA) Symptom Score, as documented in regulatory filings.


Q: What is the scientific basis for the claims made about Prostacure?

A: The medication is classified as an alpha-blocker. It works by selectively blocking certain nerve signals (alpha-1a adrenoceptors) found mainly on the muscles in the prostate and bladder neck. Blocking these signals causes the muscles to relax, which in turn helps improve urine flow.


Q: Does Prostacure affect the results of a PSA blood test?

A: Official product information indicates that the active ingredient in Prostacure does not cause a significant decrease in Prostate-Specific Antigen (PSA) levels when used for up to 12 months. The lack of effect on PSA means that changes in PSA levels should still be carefully evaluated by a healthcare professional.


Q: Is it normal to feel slightly dizzy or lightheaded when starting Prostacure?

A: Yes, feeling dizzy or lightheaded can be a common side effect of the active ingredient (tamsulosin). This is often related to orthostatic hypotension, which is a drop in blood pressure that can occur when standing up quickly. Due to the potential for dizziness, patients should be aware of this risk, particularly when changing position suddenly.


Q: Is Prostacure considered a first-line treatment for BPH?

A: Public health guidelines often indicate that the class of medication to which Prostacure belongs (alpha-blockers) is generally regarded as one of the first-choice drug treatment options for managing the symptoms of an enlarged prostate (BPH).


Q: Is Prostacure used only for prostate issues, or does it have other benefits?

A: Prostacure is specifically approved by regulatory bodies only for treating the signs and symptoms associated with Benign Prostatic Hyperplasia (BPH) in men. It is not approved for the treatment of any other conditions.


Q: What is the general mechanism or theory behind how Prostacure works?

A: The general theory of action is that by blocking specific receptors (alpha-1a adrenoceptors) in the lower urinary tract, the drug reduces muscular tension around the urethra. This relaxation lowers resistance at the bladder outlet, which is intended to allow urine to flow more freely.


Q: Does Prostacure cure the underlying condition, or does it just manage symptoms?

A: Prostacure is a medication intended for symptomatic relief. It helps manage the uncomfortable urinary symptoms caused by an enlarged prostate by relaxing muscles, but it does not shrink the prostate tissue or cure the underlying condition itself.


Q: Are there any foods or drinks I should avoid while on Prostacure?

A: There are no specific food or drink restrictions generally advised, other than the requirement to take the capsule with the same meal each day. However, official information notes that alcohol can increase the potential for low blood pressure effects, and therefore use with alcohol should be discussed with a healthcare provider.


Q: Can I drink alcohol while taking Prostacure, and does it reduce effectiveness?

A: Official warnings note that alcohol can increase the risk of low blood pressure side effects, such as dizziness. Any use of alcohol should be clarified with a healthcare provider, especially when first starting the medication.


Q: Why is Prostacure sometimes prescribed to younger patients?

A: Official regulatory documents clearly state that Prostacure is not indicated or approved for use in the pediatric population (individuals under 18 years of age). Its approved use is strictly limited to adult males for BPH.


Q: Has Prostacure been approved by major regulatory bodies globally?

A: The active ingredient in Prostacure, tamsulosin, is widely recognized and approved by major regulatory bodies worldwide, including the U.S. FDA, and is used under various trade names globally for BPH symptoms.


Q: Is it possible for a generic version of Prostacure to be less effective than the brand name?

A: Regulatory requirements dictate that generic versions of a drug must contain the same active ingredient and meet strict government standards for equivalent effectiveness (bioequivalence) as the original brand-name product.


Q: What should I do if I experience mild nausea after taking Prostacure?

A: Mild side effects like nausea can occur when starting the medication. If symptoms like nausea are persistent, severe, or concerning, seeking guidance from a healthcare professional is necessary.


Q: How long after stopping Prostacure will the medication be completely out of my system?

A: The time it takes for a medication to be eliminated is related to its half-life. Official product information states the apparent half-life of the active ingredient (tamsulosin) in the patient population is approximately 14 to 15 hours.


Q: Are there any studies comparing Prostacure to placebo?

A: Yes, the effectiveness of the active ingredient in Prostacure for managing BPH symptoms was established and verified in multiple randomized, double-blind, placebo-controlled clinical trials, as detailed in regulatory documents.


Q: Does Prostacure carry any warnings about driving or operating machinery?

A: Yes, official warnings advise caution regarding activities such as driving, operating heavy machinery, or performing hazardous tasks. This is due to the potential for symptomatic low blood pressure, which may cause dizziness or fainting.


Q: Why does the packaging for Prostacure mention talking to a doctor about liver function?

A: Regulatory documents indicate that the use of the medication is not recommended in patients with severe hepatic (liver) impairment. This restriction necessitates discussing existing liver function with a healthcare provider prior to initiation or continuation of treatment.


Q: How often are follow-up appointments typically needed when taking Prostacure?

A: Medical guidelines often recommend an initial follow-up appointment within the first few weeks to assess symptom response. Regulatory guidance and BPH guidelines usually recommend ongoing monitoring, and the frequency of follow-up appointments is determined by the healthcare provider.


Q: What evidence exists about Prostacure's safety profile in long-term use?

A: The safety profile has been documented in clinical trials that studied continuous use for periods up to 12 months. The medication is generally used continuously for symptom management, and safety beyond the clinical trial period requires ongoing monitoring and assessment by a healthcare provider.

How should Prostacure be stored and disposed of?

How to Store and Dispose of Prostacure (Tamsulosin Hydrochloride)

Official regulatory guidelines dictate specific storage and disposal requirements for Prostacure capsules to maintain product stability and ensure safety.


Storage Requirements

The medicine must be stored at room temperature, typically defined as below 25 C or 30 C, and must be protected from excess heat and moisture. Keep the capsules in their original container, tightly closed. A mandatory requirement is to keep this medicine out of the sight and reach of children.


️ Disposal Instructions

Do not throw away Prostacure via wastewater or household waste. Disposal of any unused or expired capsules must be performed in accordance with local requirements. Patients should consult a pharmacist for guidance on proper disposal or to utilize a drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prostacure found in:

A-Z Index: